Conference Support: The 13th International Drug Delivery Symposium

会议支持：第13届国际药物递送研讨会

• 批准号: 7267570
• 负责人: DAVID W GRAINGER
• 金额: $ 1.1万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-23 至 2008-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7267570
• 关键词: Address; Area; Award; Biocompatible Materials; Biomedical Engineering; Biotechnology; Characteristics; Cities; Class; Clinical; Disease; Drug Delivery Systems; Drug Formulations; Faculty; Gender; Gene Delivery; Image; International; Leadership; Molecular; Oral; Participant; Penetration; Persons; Pharmaceutical Preparations; Pharmacologic Substance; Population; Research; Research Personnel; Scientist; Sodium Chloride; Solutions; Students; Thinking; Tissue Engineering; Tissues; Translational Research; Travel; Treatment Efficacy; Underrepresented Minority; Work; clinical application; cost; design; fundamental research; novel; posters; programs; symposium

DESCRIPTION (provided by applicant): This proposal by the Program Co-Chair (as PI) seeks support of selected junior and protected-class podium speakers, and 3 graduate student poster research presentation awards at the Thirteenth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, February 26-28, 2007. The general theme of the 2007 technical drug delivery conference is centered on "overcoming long-standing barriers", more specifically focused on addressing molecular, cellular and tissue barriers to effective drug targeting, penetration, formulation, and efficacy. The program design maintains its highly regarded tradition in assembling oral sessions comprising world-renowned pharmaceutical scientists, bioengineers, industrial scientists, and clinicians all seeking solutions to compelling drug delivery problems. Overall specific aims in producing this meeting are to: 1) Provide a rich, diverse scientific program focusing on both fundamental and clinical phenomena that limit drug therapeutic efficacy in several important disease contexts (i.e., hurdles of translational research), as well as key areas of biotechnology where investigators are proposing solutions to drug delivery, imaging, tissue engineering problems; 2) Gather a group of presenters and participants comprising widely acknowledged thought-leaders as well as younger, aggressive, and vibrant faculty and research trainees already noted for novel and quality work. Speakers and session chairs will represent both academic and commercial drug delivery efforts: perspectives and leadership from both fundamental research and clinical applications. The program is already mature and detailed herein, including persons from underrepresented scientific groups. Emphasis will be placed on supporting the more junior participants and under-represented populations involved in these areas. This group will similarly represent the gender diversity characteristic of faculty working in these areas; 3) Facilitate interactions between junior and under-represented minority scientists and faculty working in the formulation, biotechnology, gene delivery, biomaterials, drug targeting, bio-conjugation and imaging areas with prominent senior and international investigators in the field. Support is requested both for selected speaker participation costs and 3 junior scientist poster travel awards.

描述(由申请人提供)：本计划联合主席(作为PI)寻求在2007年2月26-28日于德克萨斯州盐湖城举行的第十三届国际药物输送系统最新进展研讨会上获得选定的初级和受保护级别的讲台演讲者和3名研究生海报研究演示文稿奖。2007年药物输送技术会议的总主题是“克服长期存在的障碍”，更具体地侧重于解决有效药物靶向、渗透、配方和疗效的分子、细胞和组织障碍。该计划的设计保持了其备受推崇的传统，由世界知名的制药科学家、生物工程师、工业科学家和临床医生组成的口头会议，他们都在寻找引人注目的药物输送问题的解决方案。举办这次会议的总体具体目标是：1)提供丰富多样的科学计划，重点关注在几种重要疾病背景下限制药物治疗效果的基本和临床现象(即，翻译研究的障碍)，以及研究人员为药物输送、成像、组织工程问题提出解决方案的生物技术关键领域；2)召集一群演讲者和参与者，其中包括公认的思想领袖以及已经以新颖和高质量的工作而闻名的年轻、积极和充满活力的教职员工和受训人员。演讲者和会议主席将代表学术和商业药物输送努力：来自基础研究和临床应用的视角和领导力。该计划已经成熟并在此详细说明，包括来自代表性不足的科学团体的人。重点将放在支持较初级参与者和参与这些领域的人数不足的人群上。这一群体将同样代表在这些领域工作的教师的性别多样性特征；3)促进初级和代表性不足的少数族裔科学家和在配方、生物技术、基因传递、生物材料、药物靶向、生物结合和成像领域工作的教师与该领域著名的资深和国际研究人员之间的互动。请为选定的演讲者参与费用和3名初级科学家海报旅行奖提供支持。